Cancer News and Research RSS Feed - Cancer News and Research Twitter

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Treatment plans may include surgery, radiation and/or chemotherapy.
Persistent enlarged lymph glands in the neck may indicate cancer

Persistent enlarged lymph glands in the neck may indicate cancer

Referring patients with unexplained swollen neck glands for specialist investigations could help to avoid some of the thousands of deaths each year from lymphoma, a type of cancer. [More]
Large majority of people in the world lack access to safe, affordable surgery and anaesthesia

Large majority of people in the world lack access to safe, affordable surgery and anaesthesia

Millions of people are dying from common, easily treatable conditions like appendicitis, fractures, or obstructed labour because they do not have access to, or can't afford, proper surgical care, according to a major new Commission, published in The Lancet. [More]
Men who receive brachytherapy more likely to be cancer-free five years later

Men who receive brachytherapy more likely to be cancer-free five years later

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. [More]
Researchers move one step closer to developing effective radiotherapy for lung cancer

Researchers move one step closer to developing effective radiotherapy for lung cancer

Radiotherapy using protons can deliver more accurate treatment to a tumour while reducing the dose to surrounding tissue. However, in mobile organs such as the lung, precise targeting of the dose is difficult. Now researchers have succeeded in making a model of breathing movement that allows for the precise measurement of narrow beams to a dummy tumour by simulating the motion and physical properties of the chest anatomy in a model, the 3rd ESTRO Forum in Barcelona, Spain, will hear today (Monday). [More]
Increasing radiotherapy can significantly improve survival for children with intracranial ependymoma

Increasing radiotherapy can significantly improve survival for children with intracranial ependymoma

Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival. [More]
Brachytherapy improves overall survival for women with inoperable early stage endometrial cancer

Brachytherapy improves overall survival for women with inoperable early stage endometrial cancer

Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research to be presented at the 3rd ESTRO Forum in Barcelona, Spain, on Sunday. [More]
Humanized mouse model may lead to better anti-cancer therapies

Humanized mouse model may lead to better anti-cancer therapies

Human tumors grown in mouse models have long been used to test promising anti-cancer therapies. However, when a human tumor is transplanted into a mouse, the mouse immune system must be knocked down so that it doesn't attack the foreign tumor tissue, thus allowing the tumor to grow. [More]
Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Investigators from Massachusetts General Hospital and the Harvard Stem Cell Institute have developed an imageable mouse model of brain-metastatic breast cancer and shown the potential of a stem-cell-based therapy to eliminate metastatic cells from the brain and prolong survival. [More]
Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia announced today that its breast imaging reporting tools and MQSA management system have been selected for use by BelleBridge, which provides telemedicine services for interpretations of breast screening and diagnostic examinations. [More]
New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. [More]

Birmingham City University event to focus on digital future of NHS

The digital future of the NHS will be the focus of a free Birmingham City University event next week. 'Healthcare in a Digital Age' takes place on Thursday 30 April and will see innovators Edward Miller and Robin Vickers lead discussions on the digitisation of patient information and the integration of services giving patients more control over their healthcare. [More]
AUDs have negative prognostic outcome with higher mortality risks in patients with HCV infection

AUDs have negative prognostic outcome with higher mortality risks in patients with HCV infection

Results presented today at The International Liver Congress 2015, show that alcohol use disorders (AUD) have a serious, negative prognostic outcome with higher mortality risks in the general population and patients with hepatitis C virus (HCV) infection in particular. [More]
New computational model helps study how emerging metastatic tumors interact with immune system

New computational model helps study how emerging metastatic tumors interact with immune system

You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage. [More]
Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease

Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease

With the introduction of Elekta's new Leksell Gamma Knife Icon, the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. [More]
iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the first Xoft Axxent Electronic Brachytherapy (eBx) System in Spain is now available at the Hospital Miguel Servet for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers. [More]
NPC recognized as top ranking company on DiversityInc Top 50 Companies for Diversity list

NPC recognized as top ranking company on DiversityInc Top 50 Companies for Diversity list

Novartis Pharmaceuticals Corporation has been named the top company for diversity for the second year in a row on the annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2015 Top 50 Companies for Diversity on April 23 at an awards ceremony in New York, NY. [More]
Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Blueprint Medicines today announced new preclinical data demonstrating that BLU-554, a selective and potent inhibitor of fibroblast growth factor receptor 4 (FGFR4), has significant anti-tumor activity in models of hepatocellular carcinoma (HCC) that are dependent on FGFR4 signaling. [More]
Proviso Partners for Health awarded IHI grant to improve community health

Proviso Partners for Health awarded IHI grant to improve community health

The Proviso Partners for Health was awarded a grant from the Institute of Healthcare Improvement to support their efforts to improve community health. Proviso Partners for Health is comprised of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and Marcella Niehoff School of Nursing as well as Proviso-Leyden Council for Community Action, Proviso East High School, Triton College, Cook County Department of Public Health and several other community organizations. [More]
Dan Theodorescu awarded Barringer Medal for distinguished contributions to urology

Dan Theodorescu awarded Barringer Medal for distinguished contributions to urology

Dan Theodorescu, MD, PhD, director of the NCI-designated University of Colorado Cancer Center and professor of Urology and Pharmacology at the University of Colorado School of Medicine was awarded the Barringer Medal this past Saturday from the American Association of Genitourinary Surgeons for his distinguished contributions to urology. [More]
Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him -- as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread. [More]
Advertisement
Advertisement